Cancer Control

T.Nguyen R.Pasick
Program Leader: Robert A. Hiatt, MD, PhD
Program Co-Leader: Tung T. Nguyen, MD

The Cancer Control Program includes 28 members from 13 academic departments in the UCSF Schools of Medicine, Nursing, and Pharmacy. The overarching goal of the Program is to focus on social, behavioral, communications, and health policy research integrating it with cancer research across the spectrum from the basic to the population sciences.

The Cancer Control Program conducts research under three themes:

  • Theme 1: Social and Behavioral Factors in Cancer
  • Theme 2: Cancer Health Disparities
  • Theme 3: Health Outcomes and Comparative Effectiveness

The goal of the Cancer Control Program is to foster and sustain an integrated transdisciplinary environment for dedicated multi-level and multi-ethnic cancer control research. The scope includes studies of mechanisms of cancer etiology at a population level, interventions from prevention through survivorship, and the application of health services research methods to understanding health care system issues. The Program’s research encompasses biological, behavioral, and social factors, as well as healthcare delivery services affecting cancer prevention and cancer care, particularly for people living in the geographic catchment area of Northern California served by the HDFCCC. This diverse population includes large proportions of African Americans, Asian Americans, and Latinos as well as those who have limited English proficiency or are otherwise disadvantaged in receiving high quality prevention and clinical care for cancer.

Our aims are to understand the social and behavioral determinants of cancer, to develop and implement interventions to reduce inequities in cancer outcomes across race/ethnic, socioeconomic and other categories, and to develop the most effective policies and health care approaches to the delivery of new knowledge, diagnostics and therapies.

The Program also adds value to the Helen Diller Family Comprehensive Cancer Center (Center) by bringing expertise in diverse populations to clinical programs; by connecting community members and clinicians; by fostering the intra-programmatic and inter-programmatic collaborations that advance knowledge in cancer disparities; and by conducting significant and successful training programs to increase the number of researchers who are under-represented minorities.